[1]
2022. In Vivo Study Of Phospholipid Naringenin Complex In Diabetes Treatment. Journal of Pharmaceutical Negative Results. (Dec. 2022), 3639–3641. DOI:https://doi.org/10.47750/pnr.2022.13.S10.439.